iSpeak Blog
As global regulators sharpen their focus on data integrity, issues have emerged around practices observed in operations that generate data used to make drug product decisions. One such practice is “testing into compliance”-- repeatedly analyzing a sample until a desired result is obtained, then reporting this value while ignoring all previous values. Regulators expect manufacturers...